Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login
The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
Twitter:
@TheCancerLetter
Facebook:
/TheCancerLetter
publication date: Jul 22, 2011
This issue is free and open to the public.
  • A Year at NCI: Harold Varmus Reflects on Provocative Questions, the Duke Scandal, Financial Disaster and Grant Review
  • Part one of a two-part interview with NCI Director Harold Varmus
  • Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication
  • ODAC Votes for Accelerated Approval for Adcetris for Two Lymphoma Indications
  • Richard Pazdur's Comments to ODAC
  • Department of Defense offering $16 million in Cancer Research Grants

Copyright (c) 2014 The Cancer Letter Inc.
Letter